Vergoeding 2020-2024 voor ATC-subgroep B01A : Antithrombotica
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| B01AA Vitamine k-antagonisten | 3.347.000 | 3.210.600 | 2.682.100 | 2.353.300 | 2.140.000 |
| B01AB Heparinegroep | 18.032.000 | 16.137.400 | 16.889.400 | 15.672.300 | 14.955.400 |
| B01AC Trombocytenaggregatieremmers excl heparine | 50.396.700 | 49.392.600 | 53.471.900 | 53.896.600 | 55.980.500 |
| B01AD Enzymen | 3.172 | 13.662 | 21.583 | 19.842 | 32.668 |
| B01AE Directe trombineremmers | 36.170.400 | 30.951.300 | 30.867.200 | 31.130.700 | 27.635.200 |
| B01AF Directe remmers van factor xa | 192.354.600 | 221.646.100 | 258.309.800 | 287.134.400 | 328.976.800 |
| B01AX Overige antithrombotica | 597.590 | 679.620 | 671.500 | 589.690 | 686.870 |
| Totaal | 300.901.462 | 322.031.282 | 362.913.483 | 390.796.832 | 430.407.438 |